Astrazeneca PLC News Headlines

AZN 
$74.48
*  
0.04
0.05%
Get AZN Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading AZN now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Pfizer Defends AstraZeneca Deal
5/12/2014 5:31:00 AM - Fox Business

AstraZeneca, Amgen Announce Positive Phase III Brodalumab Study
5/12/2014 2:39:00 AM - Dow Jones Business News

European Shares Seen Rising On Asian Cues
5/12/2014 2:07:00 AM - RTT News

Pfizer's AstraZeneca Bid Marks Tax-Fueled Trend in Cross-Border Deals
5/11/2014 7:48:00 PM - Dow Jones Business News

Pfizer CEO Defends AstraZeneca Deal; Claims Deal "win-win" For Society
5/10/2014 4:27:00 PM - RTT News

Amgen, AstraZeneca Announce Positive Results from Brodalumab Study
5/9/2014 6:15:00 PM - Dow Jones Business News

The New Logic Of M&A
5/9/2014 4:29:00 PM - Seeking Alpha

Amgen, AstraZeneca Say Ph 3 Study Of Psoriasis Drug Brodalumab Meets Goals
5/9/2014 4:18:00 PM - RTT News

Dow 30 Stock Roundup: Chevron Misses, UTX Bags $1.24B Deal - Analyst Blog
5/9/2014 2:00:00 PM - Zacks.com

Cramer's Lightning Round - AstraZeneca Wouldn't Be Good For Pfizer, It Would Be Great For Pfizer (5/8/14)
5/9/2014 5:15:00 AM - Seeking Alpha

Senators Study Ways to Stem Overseas Corporate Tax Avoidance
5/8/2014 7:09:00 PM - Dow Jones Business News

AstraZeneca Holder Signals Openness to a Pfizer Bid--Update
5/8/2014 12:01:00 PM - Dow Jones Business News

Wider-than-Expected Q1 Loss at Nektar - Analyst Blog
5/8/2014 11:20:00 AM - Zacks.com

AstraZeneca Starts PhaseIII Trial of Cancer Drug
5/8/2014 8:05:00 AM - Dow Jones Business News

Pfizer And AstraZeneca: Innovation Will Not Follow Acquisition
5/7/2014 3:44:00 PM - Seeking Alpha

Pre-Market Most Active for May 7, 2014 : WFM, TWTR, MDLZ, AZN, YHOO, QQQ, FB, YPF, FEYE, JCP, BAC, PKX
5/7/2014 8:39:58 AM - NASDAQ.com News

Growth Story: Fund Managers Buy Healthcare
5/7/2014 5:55:00 AM - Seeking Alpha

GALE Breezes Ahead, AEGR, InVivo Hammered, AZN Gets FDA Thumbs Up, OPK To Watch
5/7/2014 12:39:00 AM - RTT News

Bayer to Buy Merck's Consumer Business for $14.2 Billion-8th Update
5/6/2014 7:17:00 PM - Dow Jones Business News

Pfizer: Spending More Than $100 Billion To Rejuvenate Revenue Growth Will Not Create Long-Term Value
5/6/2014 5:15:00 PM - Seeking Alpha

ADR Shares End Mixed; UBS, Barclays Shares Active
5/6/2014 5:06:00 PM - Dow Jones Business News

Tuesday's ETF with Unusual Volume: BSCF
5/6/2014 3:32:51 PM - BNK Invest

U.K. Not Ruling Out Intervening in Pfizer AstraZeneca Deal
5/6/2014 2:25:00 PM - Dow Jones Business News

Why Pfizer Is Worth $45 With AstraZeneca
5/6/2014 12:18:00 PM - Seeking Alpha

Ukraine Weighs On European Stocks For Second Day
5/6/2014 11:56:00 AM - RTT News